Franklin Resources
CRMD icon

Franklin Resources’s CorMedix CRMD Stock Holding History

Franklin Resources’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Sell
23,436
-33,117
-59% -$262K ﹤0.01% 2871
2026
Q1 		$384K Buy
56,553
+12,602
+29% +$93.2K ﹤0.01% 2561
2025
Q4 		$511K Buy
43,951
+638
+1% +$7.05K ﹤0.01% 2398
2025
Q3 		$504K Buy
43,313
+2,893
+7% +$35K ﹤0.01% 2423
2025
Q2 		$498K Buy
40,420
+1,720
+4% +$19K ﹤0.01% 2319
2025
Q1 		$238K Buy
38,700
+16,865
+77% +$175K ﹤0.01% 2598
2024
Q4 		$177K Buy
+21,835
New +$218K ﹤0.01% 2669
2019
Q3 		– Sell
-35,580
Closed -$319K – 1522
2019
Q2 		$319K Sell
35,580
-2,314
-6% -$18.2K ﹤0.01% 1440
2019
Q1 		$358K Buy
37,894
+2,235
+6% +$20.1K ﹤0.01% 1387
2018
Q4 		$230K Buy
35,659
+1,565
+5% +$10.5K ﹤0.01% 1430
2018
Q3 		$165K Sell
34,094
-10,557
-24% -$26K ﹤0.01% 1501
2018
Q2 		$53K Buy
44,651
+3,178
+8% +$3.68K ﹤0.01% 1462
2018
Q1 		$38K Buy
41,473
+5,323
+15% +$10.6K ﹤0.01% 1498
2017
Q4 		$91K Sell
36,150
-397
-1% -$1.14K ﹤0.01% 1496
2017
Q3 		$95K Buy
36,547
+10,567
+41% +$21.9K ﹤0.01% 1470
2017
Q2 		$56K Buy
25,980
+8,137
+46% +$27.8K ﹤0.01% 1493
2017
Q1 		$145K Buy
17,843
+2,891
+19% +$27.6K ﹤0.01% 1473
2016
Q4 		$114K Buy
14,952
+1,744
+13% +$17.6K ﹤0.01% 1458
2016
Q3 		$166K Buy
13,208
+1,337
+11% +$12.5K ﹤0.01% 1474
2016
Q2 		$118K Sell
11,871
-789
-6% -$12K ﹤0.01% 1484
2016
Q1 		$168K Buy
12,660
+1,189
+10% +$11.5K ﹤0.01% 1487
2015
Q4 		$116K Sell
11,471
-402
-3% -$4.63K ﹤0.01% 1558
2015
Q3 		$118K Buy
11,873
+258
+2% +$3.98K ﹤0.01% 1568
2015
Q2 		$225K Buy
11,615
+3,446
+42% +$118K ﹤0.01% 1554
2015
Q1 		$402K Buy
+8,169
New +$194K ﹤0.01% 1473

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Franklin Resources's CRMD Position: Q2 2026 in Review

Franklin Resources reduced its CorMedix (CRMD) stake by 59% in Q2 2026, selling an estimated $262K and leaving 23,436 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2871.

Franklin Resources first reported a position in CRMD in Q1 2015 and has held it in 25 quarters since. The position peaked at $511K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Franklin Resources held 23,436 shares of CorMedix worth $184K as of Q2 2026.
  • Franklin Resources sold 33,117 CorMedix shares in Q2 2026, an estimated $262K.
  • CorMedix made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2871 holding.
  • Franklin Resources first reported a position in CorMedix in Q1 2015 and has held it in 25 quarters since.
  • Franklin Resources's CorMedix position peaked at $511K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.